Source:http://linkedlifedata.com/resource/pubmed/id/16741521
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0013879,
umls-concept:C0017262,
umls-concept:C0086022,
umls-concept:C0086222,
umls-concept:C0086860,
umls-concept:C0138741,
umls-concept:C0185117,
umls-concept:C0205112,
umls-concept:C0442335,
umls-concept:C0444669,
umls-concept:C0449255,
umls-concept:C1366489,
umls-concept:C1417779,
umls-concept:C1524063,
umls-concept:C1705099,
umls-concept:C1705733,
umls-concept:C2911684
|
pubmed:issue |
10
|
pubmed:dateCreated |
2006-9-13
|
pubmed:abstractText |
Composite promoters combining the prostate-specific antigen (PSA) enhancer core element with promoter elements derived from gene coding for human prostate-specific transglutaminase gene, prostate-specific membrane antigen gene, prostate-specific antigen, rat probasin or phosphoglycerate kinase were characterized for their ability to specifically express the enhanced green fluorescent protein (EGFP) gene in prostate versus non-prostate cancer cell lines when transferred with a human immunodeficiency virus-1-based lentiviral vector. By themselves minimal proximal promoter elements were found to inefficiently promote relevant tissue-specific expression; in all the vectors tested, addition of the PSA enhancer core element markedly improved EGFP expression in LnCaP, a cancer prostate cell line used as a model for prostate cancer. The composite promoter was inactive in HuH7, a hepatocarcinoma cell line used as a model of neighboring non-prostate cancer cells. Among the promoters tested, the combination of the PSA enhancer and the rat probasin promoter showed both high specificity and a strong EGFP expression. Neither a high viral input nor the presence of the cPPT/CTS sequence affected composite promoter behavior. Our data suggest that composite prostate-specific promoters constructed by combining key elements from various promoters can improve and/or confer tissue specific expression in a lentiviral vector context.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0929-1903
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
919-29
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:16741521-Cell Line, Tumor,
pubmed-meshheading:16741521-Enhancer Elements, Genetic,
pubmed-meshheading:16741521-Genetic Vectors,
pubmed-meshheading:16741521-Green Fluorescent Proteins,
pubmed-meshheading:16741521-Humans,
pubmed-meshheading:16741521-Lentivirus,
pubmed-meshheading:16741521-Male,
pubmed-meshheading:16741521-Promoter Regions, Genetic,
pubmed-meshheading:16741521-Prostate,
pubmed-meshheading:16741521-Prostate-Specific Antigen
|
pubmed:year |
2006
|
pubmed:articleTitle |
Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context.
|
pubmed:affiliation |
EFS Alpes Méditerranée, Marseille, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|